[Journal logo]

Volume 65 
Part 9 
Page o2087  
September 2009  

Received 30 July 2009
Accepted 30 July 2009
Online 8 August 2009

Key indicators
Single-crystal X-ray study
T = 296 K
Mean [sigma](C-C) = 0.003 Å
R = 0.031
wR = 0.085
Data-to-parameter ratio = 13.8
Details
Open access

4-(Benzylideneamino)benzenesulfonamide

aEskitis Institute for Cell and Molecular Therapies, Griffith University, Brisbane 4111, Australia
Correspondence e-mail: p.healy@griffith.edu.au

The title compound, C13H12N2O2S, formed by Schiff base condensation of benzaldehyde with sulfanilamide, crystallizes as discrete molecular species linked by N-H...N and N-H...O hydrogen bonds between the sulfamide nitrogen H atoms and the azamethine N and one sulfamide O atom, respectively, forming a two-dimensional array in the bc plane. The azamethine group is rotated slightly out of the benzaldehyde benzene plane [C-C-C-N torsion angle = 8.1 (3)°], while the dihedral angle between the two benzene rings is 30.0 (1)°.

Related literature

Condensation of substituted benzaldehydes with sulfanilamide yields a diverse array of Schiff bases which display interesting enzymatic inhibition, see Supuran et al. (1996[Supuran, C. T., Nicolae, A. & Popescu, A. (1996). Eur. J. Med. Chem. 31, 431-438.]); Lin et al. (2008[Lin, S. J., Tsai, W. J., Chiou, W. F., Yang, T. H. & Yang, L. M. (2008). Bioorg. Med. Chem. 16, 2697-2706.]). For our ongoing studies on the synthesis, structures and biological activity of organometallic Cp*Ru(II) arene complexes Loughrey et al. (2008[Loughrey, B. T., Williams, M. L., Poulsen, S.-A. & Healy, P. C. (2008). Acta Cryst. E64, m1568.], 2009[Loughrey, B. T., Williams, M. L., Healy, P. C., Innocenti, A., Vullo, D., Supuran, C. T., Parsons, P. G. & Poulsen, S.-A. (2009). J. Biol. Inorg. Chem. 14, 935-945.]). For related structures, see Chumakov et al. (2006[Chumakov, Y. M., Tsapkov, V. I., Bocelli, G., Antonsyak, B. Y., Palomares-Sanches, S. A., Oritz, R. S. & Gulya, A. P. (2006). J. Struct. Chem. 47, 923-929.]); Subashini et al. (2009[Subashini, A., Hemamalini, M., Muthiah, P. T., Bocelli, G. & Cantoni, A. (2009). J. Chem. Crystallogr. 39, 112-116.]).

[Scheme 1]

Experimental

Crystal data
  • C13H12N2O2S

  • Mr = 260.32

  • Monoclinic, P 21 /c

  • a = 14.5206 (8) Å

  • b = 11.4992 (6) Å

  • c = 7.7846 (5) Å

  • [beta] = 103.287 (6)°

  • V = 1265.04 (13) Å3

  • Z = 4

  • Mo K[alpha] radiation

  • [mu] = 0.25 mm-1

  • T = 296 K

  • 0.43 × 0.31 × 0.20 mm

Data collection
  • Oxford-Diffraction Gemini S Ultra diffractometer

  • Absorption correction: multi-scan (CrysAlis RED; Oxford Diffraction, 2007[Oxford Diffraction (2007). CrysAlis CCD and CrysAlis RED. Oxford Diffraction Ltd, Abingdon, England.]) Tmin = 0.900, Tmax = 0.952

  • 8991 measured reflections

  • 2253 independent reflections

  • 1928 reflections with I > 2[sigma](I)

  • Rint = 0.018

Refinement
  • R[F2 > 2[sigma](F2)] = 0.031

  • wR(F2) = 0.085

  • S = 1.05

  • 2253 reflections

  • 163 parameters

  • H-atom parameters constrained

  • [Delta][rho]max = 0.27 e Å-3

  • [Delta][rho]min = -0.24 e Å-3

Table 1
Hydrogen-bond geometry (Å, °)

D-H...A D-H H...A D...A D-H...A
N1-H11...N4i 0.86 2.14 2.9955 (18) 171
N1-H12...O11ii 0.87 2.13 2.9845 (19) 171
Symmetry codes: (i) -x+2, -y+1, -z+1; (ii) [x, -y+{\script{1\over 2}}, z+{\script{1\over 2}}].

Data collection: CrysAlis CCD (Oxford Diffraction, 2007[Oxford Diffraction (2007). CrysAlis CCD and CrysAlis RED. Oxford Diffraction Ltd, Abingdon, England.]); cell refinement: CrysAlis RED (Oxford Diffraction, 2007[Oxford Diffraction (2007). CrysAlis CCD and CrysAlis RED. Oxford Diffraction Ltd, Abingdon, England.]); data reduction: CrysAlis RED; program(s) used to solve structure: SIR97 (Altomare et al., 1999[Altomare, A., Burla, M. C., Camalli, M., Cascarano, G. L., Giacovazzo, C., Guagliardi, A., Moliterni, A. G. G., Polidori, G. & Spagna, R. (1999). J. Appl. Cryst. 32, 115-119.]); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008[Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.]); molecular graphics: ORTEP-3 for Windows (Farrugia, 1997[Farrugia, L. J. (1997). J. Appl. Cryst. 30, 565.]); software used to prepare material for publication: PLATON (Spek, 2009[Spek, A. L. (2009). Acta Cryst. D65, 148-155.]).


Supplementary data and figures for this paper are available from the IUCr electronic archives (Reference: TK2519 ).


Acknowledgements

We acknowledge support of this work by Griffith University, the Queensland University of Technology and the Eskitis Institute for Cell and Molecular Therapies.

References

Altomare, A., Burla, M. C., Camalli, M., Cascarano, G. L., Giacovazzo, C., Guagliardi, A., Moliterni, A. G. G., Polidori, G. & Spagna, R. (1999). J. Appl. Cryst. 32, 115-119.  [ISI] [CrossRef] [ChemPort] [details]
Chumakov, Y. M., Tsapkov, V. I., Bocelli, G., Antonsyak, B. Y., Palomares-Sanches, S. A., Oritz, R. S. & Gulya, A. P. (2006). J. Struct. Chem. 47, 923-929.  [ISI] [CrossRef] [ChemPort]
Farrugia, L. J. (1997). J. Appl. Cryst. 30, 565.  [CrossRef] [details]
Lin, S. J., Tsai, W. J., Chiou, W. F., Yang, T. H. & Yang, L. M. (2008). Bioorg. Med. Chem. 16, 2697-2706.  [CrossRef] [PubMed] [ChemPort]
Loughrey, B. T., Williams, M. L., Healy, P. C., Innocenti, A., Vullo, D., Supuran, C. T., Parsons, P. G. & Poulsen, S.-A. (2009). J. Biol. Inorg. Chem. 14, 935-945.  [ISI] [CrossRef] [PubMed] [ChemPort]
Loughrey, B. T., Williams, M. L., Poulsen, S.-A. & Healy, P. C. (2008). Acta Cryst. E64, m1568.  [CSD] [CrossRef] [details]
Oxford Diffraction (2007). CrysAlis CCD and CrysAlis RED. Oxford Diffraction Ltd, Abingdon, England.
Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.  [CrossRef] [details]
Spek, A. L. (2009). Acta Cryst. D65, 148-155.  [ISI] [CrossRef] [details]
Subashini, A., Hemamalini, M., Muthiah, P. T., Bocelli, G. & Cantoni, A. (2009). J. Chem. Crystallogr. 39, 112-116.  [ISI] [CSD] [CrossRef] [ChemPort]
Supuran, C. T., Nicolae, A. & Popescu, A. (1996). Eur. J. Med. Chem. 31, 431-438.  [CrossRef] [ChemPort] [ISI]


Acta Cryst (2009). E65, o2087  [ doi:10.1107/S1600536809030256 ]

This is an open-access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.